Learn About Scaling and Automating the End-to-End Cell Therapy Manufacturing Workflow

Fill out the form below to download the article

Whether you're new to cell therapy manufacturing or looking to expand your existing processes and knowledge base, cell therapy manufacturing leaders from PACT Pharma Inc. and Thermo Fisher Scientific review how modular instrumentation platforms can enable automation and standardization of the end-to-end manufacturing workflow.

You'll learn:

• Scaling and automating the cell therapy manufacturing process
• The safety and regulatory advantages of non-viral transfection for cell therapy
• A highly efficient non-viral precision genome engineering process to manufacture personalized cell therapies for solid tumors